Kriti Jindal
IQVIA (United Kingdom) · 10 works · 4 citations · h-index 1
Top works
- 844P Progression -free survival prediction of multiple myeloma patients in five European countries using machine learning models
- 372P Microsatellite instability testing practices in colorectal cancer patients, in Europe and Asia
- MSI/MMR test usage and checkpoint inhibitor practices in Europe.
- 774P Adoption of immune checkpoint inhibitors (ICIs) in bladder cancer: Findings from a real-world study in EU5
- Usage pattern of anticoagulants in oncology patients receiving active anticancer therapies in Europe and Asia.
- Uptake of Novel Therapies into First-Line Treatment for AML Patients - EU5 Perspective
- 249P The CDK4/6 inhibitors takeover of the HR+/HER2- locally advanced to metastatic breast cancer market in the EU5: Findings from a real-world study
- Usage Pattern of CAR-T and CD3xCD20 T-Cell-Engaging Bi-Specific Monoclonal Antibodies in B-NHL Patients in EU4 + UK
- Analysis of Patient Characteristics and Treatment Progression Patterns in R/R DLBCL Patients Prior to CAR T-Cell Therapy in EU4+UK Countries
- Uptake of Novel Therapies Into First-Line Treatment for Acute Myeloid Leukemia Patients: EU4 + UK Perspective